NHS Lanarkshire

GLP-1 Receptor Agonists Linked to Serious Side Effects and Regulatory Scrutiny

6 months ago

• A recent death in the UK has been linked to tirzepatide (Mounjaro), raising concerns about the safety of GLP-1 receptor agonists. • Online pharmacies selling weight-loss medications face increased regulatory scrutiny due to breaches in safety standards. • Clinical trials show GLP-1 drugs like Wegovy reduce cardiovascular events, but side effects and individual risks must be considered. • Experts caution against viewing GLP-1 drugs as a "silver bullet" for obesity, emphasizing the need for careful patient selection and monitoring.